Uranium Energy’s Production Restart and NRC Win Fail to Halt 33% Rout as $52M Loss Bites

Uranium Energy has fired up a new Texas wellfield, secured a regulatory docket for a conversion plant, and pushed its mine output in Wyoming higher — but the market has responded with a brutal sell-off. The stock slid 33% in a single week, touching €8.15 on Wednesday, after the company reported a $52.3 million net loss for its fiscal third quarter on precisely zero uranium sales.

The loss, which came in at $0.11 per share, was far wider than analysts had anticipated. Management is deliberately selling no uranium, instead stockpiling physical material under an unhedged strategy. At the end of April, the company held roughly 1.46 million pounds of uranium inventory with a market value of $127 million.

Operating expenses surged almost 74% year-over-year to $40.8 million, driven by the expansion of domestic production. A separate $90 million book loss on equity investments added to the red ink. Still, the balance sheet remains solid: cash and equivalents total $794 million, and the company carries no long-term debt.

Production milestones on two fronts

In Texas, the Burke Hollow in-situ recovery project began operations in early April, marking the largest new ISR project to start up in the US in more than a decade. Uranium Energy now operates two of the country’s three licensed ISR production platforms. The ion-exchange plant at Burke Hollow came online with a capacity of 2,500 gallons per minute.

At the Christensen Ranch site in Wyoming, the company produced 32,195 pounds of uranium concentrate during the quarter. Three new header houses at Wellfield 11 went into service near the end of the period, and five more are under construction. Cash production costs came in at $46.69 per pound. Management expects costs to decline in the fourth quarter as the new plants run for a full period.

Should investors sell immediately? Or is it worth buying Uranium Energy?

Further north, at the Roughrider project in Saskatchewan, the core drilling program is more than 80% complete, laying the groundwork for a pre-feasibility study.

Regulatory progress offers long-term promise, near-term uncertainty

On June 9, Uranium Energy’s subsidiary US Uranium Refining & Conversion Corp received a docket number from the Nuclear Regulatory Commission — the formal first step toward licensing a planned uranium conversion facility. The company is working with engineering firm Fluor on design work in Greenville, South Carolina, and will only submit a full license application once site selection and engineering are finalised. The project remains pre-licence and pre-site, meaning a long road ahead.

The strategic backdrop is supportive. In April, the US Department of Energy announced its “Nuclear Dominance — 3 by 33” initiative, which aims to secure the entire nuclear fuel cycle via the Defense Production Act Nuclear Fuel Cycle Consortium. That reinforces the rationale for Uranium Energy’s conversion plans — but execution risk remains high.

Analysts stay bullish despite technical carnage

The stock now trades nearly 53% below its January high. With a 50-day moving average that sits 31% above the current price, the technical picture looks ugly. But the relative strength index has fallen to around 30, signalling an oversold condition.

Wall Street is holding firm. Goldman Sachs maintains a buy rating on the stock, trimming its price target from $18 to $16. H.C. Wainwright keeps a far more aggressive $26.75 target, pointing to the long-term value of the company’s uranium inventory. The next major milestone for investors comes on July 23, 2026, when Uranium Energy holds its annual general meeting in Vancouver, where management is expected to provide more details on production expansion and the integration of the Sweetwater complex.